Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer

BACKGROUND: c-Met and EGFR receptors are widely expressed on cancer cells; they are implicated in the development and progression of cancer through a plethora of effects on cell cycle progression, apoptosis, motility and metastasis and are potential targets for combination therapy. EGFR receptor tyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Puri, Neelu, Salgia, Ravi
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669728/
https://www.ncbi.nlm.nih.gov/pubmed/19240370
http://dx.doi.org/10.4103/1477-3163.44372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669728/
https://www.ncbi.nlm.nih.gov/pubmed/19240370
http://dx.doi.org/10.4103/1477-3163.44372

Ejemplares similares